Detail
| LncRNA Name | PEG10 |
| Synonyms | PEG10, EDR, HB-1, MEF3L, 2-Mar, Mart2, RGAG3, RTL2, SIRH1 |
| Region | GRCh38_7:94656325-94669695 Sequence |
| Ensembl | ENSG00000242265 |
| RefSeq | NA |
| Circulating | ✘ |
| Drug-resisitant | ✔ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | diffuse large B-cell lymphoma |
| ICD-0-3 | M9680/3 |
| Methods | qPCR, RNAi etc. |
| Sample | DLBCL tissues, cell lines (OCI-LY-3, OCI-LY-7, OCI-LY-10 etc.) |
| Expression Pattern | up-regulated |
| Function Description | We first found that the expression of PEG10 was upregulated in DLBCL tumorous tissues and that cell lines compared with the normal. Moreover, we illustrated that PEG10 was significantly correlated with B symptoms, IPI score, CHOP-like treatment and rituximab. |
| Pubmed ID | 25864113 |
| Year | 2015 |
| Title | Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity. |
| External Links |
| Links for PEG10 | GenBank HGNC lncrnadb Noncode |
| Links for diffuse large B-cell lymphoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.